Real-World Outcomes Of Underrepresented Patient Populations Treated With Immune Checkpoint Inhibitors (Icis): African American Descent, Poor Ecog Performance Status, And Chronic Viral Infections.
JOURNAL OF CLINICAL ONCOLOGY（2019）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要